Organogenesis Holdings Inc., a regenerative tissue medical company that produces bioengineered replacement skin and advanced wound care products for the surgical and sports medicine markets, will expand its manufacturing capacity after signing a full-building lease at 100 Technology Road in Smithfield, Rhode Island.
Massachusetts-based regenerative tissue medical firm expands in Rhode Island
Organogenesis signs full-building lease to establish a biomanufacturing facility at 100 Technology Road in Smithfield
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Companies
- The Davis Companies
Real Estate
- Contacts
- Mark Winters
Vice Chairman, Newmark
- Tyler McGrail
Executive Managing Director, Newmark